MarketWatchStudy finds Pfizer's antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant ...Aug 25, 2022more_vert
TIMEPaxlovid Is Most Effective in People 65 and Up, Study FindsAug 24, 2022Alice ParkBy Alice Parkmore_vert
USA TODAYPfizer COVID pill provides little or no benefit in adults 40 to 65Aug 24, 2022Matthew PerroneBy Matthew Perronemore_vert